Project Twenty21 & Cellen

Cellen Therapeutics is proud to have partnered with Project Twenty21, led by Professor David Nutt and Drug Science. To find out more about the launch of largest European observational registry for Medical Cannabis, click here.

Medical Cannabis for UK patients

Cellen Therapeutics’ personalised Medical Cannabis formulations are uniquely developed with our partners for patients living with chronic conditions

Combining innovative technology with medical expertise

Cellen Therapeutics’ personalised Medical Cannabis formulations are revolutionary for patients. The medicines are manufactured in the UK by our partners using only pharmaceutical grade ingredients, and robustly tested in independent laboratories.

Research Driven

Cellen Therapeutics is led by NHS experts and cutting-edge research.

Patient-Centred

Patients are at the heart of everything we do and we take pride in our personalised offerings.

High Quality Standards

We only work with partners that uphold the highest EU GMP standards

We are an independent UK based company built by NHS experts

Welcome to the future of Medical Cannabis

The medicines are formulated according to patients’ specific dosing requirements, and we adapt the content, concentration and the presentation of our formulations to match their specific needs.

Read Cellen Therapeutics’s latest blog posts to keep up with our news, updates and opinions! 

Learn more

Please contact us to find out more about us

Cannon Place

78 Cannon Street

London

United Kingdom

EC4N 6AF

020 4522 8805

  • White Facebook Icon
  • White Twitter Icon
  • White Instagram Icon
  • White LinkedIn Icon

© 2020 Cellen™ All rights reserved